IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Recent Advances in Drug Delivery and Formulation

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

1.28

h-Index

2024-2025

 44

Rank

2024-2025

 17517

SJR

2024-2025

 0.275

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Recent Advances in Drug Delivery and Formulation
Abbreviation Recent Adv. Drug Deliv. Formul.
Publication Type Journal
Subject Area, Categories, Scope Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)
h-index 44
Overall Rank/Ranking 17517
SCImago Journal Rank (SJR) 0.275
Impact Score 1.28
Publisher Bentham Science Publishers
Country United Arab Emirates
ISSN 26673886, 26673878
Best Quartile Q3
Coverage History 2021-2024




About Recent Advances in Drug Delivery and Formulation


Recent Advances in Drug Delivery and Formulation is a journal covering the technologies/fields/categories related to Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3). It is published by Bentham Science Publishers. The overall rank of Recent Advances in Drug Delivery and Formulation is 17517. According to SCImago Journal Rank (SJR), this journal is ranked 0.275. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 44. The best quartile for this journal is Q3.

The ISSN of Recent Advances in Drug Delivery and Formulation journal is 26673886, 26673878. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Recent Advances in Drug Delivery and Formulation is cited by a total of 72 articles during the last 3 years (Preceding 2024).


Recent Advances in Drug Delivery and Formulation Impact IF 2024-2025


The Impact IF 2024 of Recent Advances in Drug Delivery and Formulation is 1.28, which is computed in 2025 as per its definition. Recent Advances in Drug Delivery and Formulation IF is increased by a factor of 0 and approximate percentage change is 0% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Recent Advances in Drug Delivery and Formulation Impact IF 2025 Prediction


Impact IF 2024 of Recent Advances in Drug Delivery and Formulation is 1.28. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Recent Advances in Drug Delivery and Formulation. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 1.28
2023 1.28
2022 1.72
2021 1.69
2020 1.94
2019 1.18
2018 0.64
2017 1.14
2016 1.33
2015 1.48
2014 1.16

Recent Advances in Drug Delivery and Formulation h-index


  Table Setting

Recent Advances in Drug Delivery and Formulation has an h-index of 44. It means 44 articles of this journal have more than 44 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Recent Advances in Drug Delivery and Formulation ISSN


The ISSN of Recent Advances in Drug Delivery and Formulation is 26673886, 26673878. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Recent Advances in Drug Delivery and Formulation Rank and SCImago Journal Rank (SJR)


The overall rank of Recent Advances in Drug Delivery and Formulation is 17517. According to SCImago Journal Rank (SJR), this journal is ranked 0.275. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Recent Advances in Drug Delivery and Formulation by Year


Year SJR
2025/2026 Coming Soon
2024 0.275
2023 0.276
2022 0.347
2021
2020
2019
2018
2017
2016
2015
2014

Ranking of Recent Advances in Drug Delivery and Formulation by Year


Year Ranking
2025/2026 Coming Soon
2024 17517
2023 16543
2022 13776
2021 28018
2020 34529
2019 32261
2018 33750
2017 34515
2016 33964
2015 33451
2014 32726

Recent Advances in Drug Delivery and Formulation Publisher


Table Setting

Recent Advances in Drug Delivery and Formulation is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2021-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Recent Advances in Drug Delivery and Formulation is Recent Adv. Drug Deliv. Formul.. This abbreviation ('Recent Adv. Drug Deliv. Formul.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Recent Advances in Drug Delivery and Formulation


If your research field is/are related to Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Recent Advances in Drug Delivery and Formulation?

Recent Advances in Drug Delivery and Formulation latest impact IF is 1.28. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.94 (2020) and 0.64 (2018), respectively, in the last 11 years. Moreover, its average IS is 1.35 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Recent Advances in Drug Delivery and Formulation?

The Recent Advances in Drug Delivery and Formulation has an SJR (SCImago Journal Rank) of 0.275, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.347 in 2022 and the lowest being in 2021. Furthermore, the average SJR of the Recent Advances in Drug Delivery and Formulation over the previous 11-year period stands at 1.35.


What's the latest h-index of the Recent Advances in Drug Delivery and Formulation?

The latest h-index of the Recent Advances in Drug Delivery and Formulation is 44.


Who's the publisher of the Recent Advances in Drug Delivery and Formulation?

The Recent Advances in Drug Delivery and Formulation is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.


What's the current ranking of the Recent Advances in Drug Delivery and Formulation?

The Recent Advances in Drug Delivery and Formulation is currently ranked 17517 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 13776 in 2022 and its lowest position of 34529 in 2020.


What's the abbreviation or short name for the Recent Advances in Drug Delivery and Formulation?

The standard ISO4 abbreviation for the Recent Advances in Drug Delivery and Formulation is Recent Adv. Drug Deliv. Formul..


Is the "Recent Advances in Drug Delivery and Formulation" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Recent Advances in Drug Delivery and Formulation is classified as a journal that the Bentham Science Publishers publishes.


What's the scope or major areas of the Recent Advances in Drug Delivery and Formulation?

The Recent Advances in Drug Delivery and Formulation encompasses the following areas:

  • Biomedical Engineering
  • Medicine (miscellaneous)
  • Pharmaceutical Science

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Recent Advances in Drug Delivery and Formulation?

The Recent Advances in Drug Delivery and Formulation is assigned the following International Standard Serial Numbers (ISSN): 26673886, 26673878.


What's the best quartile of the Recent Advances in Drug Delivery and Formulation?

The best quartile for the Recent Advances in Drug Delivery and Formulation is Q3 (2024).


What's the coverage history of the Recent Advances in Drug Delivery and Formulation?

The Recent Advances in Drug Delivery and Formulation coverage history can be summarized as follows: 2021-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Zeitschrift fur Germanistische Linguistik journal 27452 Walter de Gruyter GmbH 17 0.29
Clinical Medicine and Research journal 14921 Marshfield Clinic 64 1.25
Journal of Competition Law and Economics journal 11978 Oxford University Press 34 0.94
International Journal of Mathematical Education in Science and Technology journal 6477 Taylor and Francis Ltd. 45 1.82
Sex Education journal 6348 Routledge 51 2.49
Tekstilec trade journal 17340 University of Ljubljana Press 16 1.29
Indian Phytopathology journal 16772 Springer 20 0.91
Built Environment journal 16252 Alexandrine Press 51 0.95
Journal of Immigrant and Refugee Studies journal 7357 Routledge 39 2.17
Archiv fur Geflugelkunde journal 28770 Verlag Eugen Ulmer 30 0.00

Check complete list




Year wise Impact Score (IS) of Recent Advances in Drug Delivery and Formulation

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 1.28
2023 1.28
2022 1.72
2021 1.69
2020 1.94
2019 1.18
2018 0.64
2017 1.14
2016 1.33
2015 1.48
2014 1.16



Top Journals/Conferences in Biomedical Engineering

Nature Biotechnology
Nature Research | United Kingdom

Nature Nanotechnology
Nature Publishing Group | United Kingdom

Nature Biomedical Engineering
Nature Research | United Kingdom

Nature Reviews Bioengineering
Springer Nature | United Kingdom

Advanced Photonics
SPIE | United States

Bioactive Materials
KeAi Communications Co. | Netherlands

Annual review of biomedical data science
Annual Reviews Inc. | United States

Annual Review of Biomedical Engineering
Annual Reviews Inc. | United States

Nano Today
Elsevier B.V. | Netherlands

Additive Manufacturing
Elsevier B.V. | Netherlands

See All

Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Research | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Nature Medicine
Nature Research | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

Physiological Reviews
American Physiological Society | United States

See All

Top Journals/Conferences in Pharmaceutical Science

Advanced Drug Delivery Reviews
Elsevier B.V. | Netherlands

Nano Today
Elsevier B.V. | Netherlands

Journal of Controlled Release
Elsevier B.V. | Netherlands

Advanced healthcare materials
John Wiley and Sons Inc | United States

Journal of Nanobiotechnology
BioMed Central Ltd | United Kingdom

Asian Journal of Pharmaceutical Sciences
Shenyang Pharmaceutical University | China

Apoptosis : an international journal on programmed cell death
Springer | United States

Phytomedicine
Elsevier GmbH | Germany

Bioengineering and Translational Medicine
John Wiley and Sons Inc | United States

Journal of Pharmaceutical Analysis
Xi'an Jiaotong University | China

See All